Results
Mahamaya Lifesciences FY26 Revenue Up 24.5% to ₹328.87 Cr
Mahamaya Lifesciences reported FY26 revenue of ₹3,288.73 lakhs, up 24.5% YoY, with EBITDA growing 32.06% to ₹342.59 lakhs.
PAT increased 28.97% to ₹165.23 lakhs despite ₹411 lakhs in accounting adjust
